Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome.
BACKGROUND
Concomitant evaluation of the metabolic and growth-promoting effects of growth hormone (GH) therapy in Turner syndrome (TS) may be used in the prediction of the growth response to GH therapy.


OBJECTIVE
To evaluate the metabolic effects of GH therapy in TS and correlation with the short-term growth response.


METHODS
24 prepubertal children with TS, aged 9.4 +/- 2.6 years were followed for auxology and IGF-I, IGFBP-3, leptin, ghrelin, adiponectin, lipids and OGTT results in a prospective multicenter study.


METHODS
GH (Genotropin) in a dose of 50 microg/kg/day for 1 year.


RESULTS
Height standard deviation score (SDS) increased from -3.9 +/- 1.5 to -3.5 +/- 1.4 (p = 0.000) on therapy. BMI did not change. IGF-I SDS increased from -2.3 +/- 0.4 to -1.6 +/- 1.1 at 3 and 6 months (p = 0.001) and decreased thereafter. Serum leptin decreased significantly from 2.3 +/- 3.9 to 1.7 +/- 5.3 ng/ml (p = 0.022) at 3 months and increased afterwards. Serum ghrelin decreased from 1.2 +/- 0.8 to 0.9 +/- 0.4 ng/ml (p = 0.005) with no change in adiponectin. Basal and stimulated insulin levels also increased significantly. Delta height SDS over 1 year showed a significant correlation with Delta IGF-I(0-3 months) (r = 0.450, p = 0.027).


CONCLUSIONS
IGF-I may be considered as a marker of growth response in TS at short term. Leptin shows a decrease at short term but does not have a correlation with growth response. The decrease in ghrelin in face of unchanged weight seems to be associated with increase in IGF-I and insulin levels. The unchanged adiponectin levels in spite of an increase in insulin levels indicates that adiponectin is mainly affected by weight, not insulin.
Darendeliler
Feyza
F
Pediatric Endocrinology Unit, Department of Pediatrics, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey. feyzad@istanbul.edu.tr
Aycan
Zehra
Z
Cetinkaya
Ergun
E
Vidilisan
Sadi
S
Bas
Firdevs
F
Bideci
Aysun
A
Demirel
Fatma
F
Darcan
Sukran
S
Buyukgebiz
Atilla
A
Yildiz
Metin
M
Berberoglu
Merih
M
Arslanoglu
Ilknur
I
Bundak
Ruveyde
R
D052242:Adiponectin / Q000097:blood; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D005260:Female; D054439:Ghrelin; D006128:Growth / Q000187:drug effects*; D019382:Human Growth Hormone / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood; D036361:Peptide Hormones / Q000097:blood / Q000187:drug effects*; D014280:Triglycerides / Q000097:blood; D014424:Turner Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology
D052242:Adiponectin; D054439:Ghrelin; D020738:Leptin; D036361:Peptide Hormones; D014280:Triglycerides; D019382:Human Growth Hormone; D002784:Cholesterol